Explore evidence

3.7 log10_c/mLThe median baseline viral load was 3.7 log10 copies/mL.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

41.2 %The death rate among the eighty patients with cryptococcal meningitis was 41.2%.

Côte d'Ivoireméningite cryptococciqueobserved 2005-2008published 2012Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

387 cells/μLThe median CD4 count was 387 cells/μL.

Côte d'IvoireVIH/sidapublished 2022HIV medicineeurope_pmcdocument of 6 observations

11.5 per_100_person-yearsThe incidence of first serious event among HIV-infected adults receiving antiretroviral treatment was 11.5 per 100 person-years overall.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

16.5 %Pretreatment HIV drug resistance (PDR) frequency was 16.5% in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 9 observationsDOI 10.1093/jac/dky443

143 per_microlitreAverage parasite densities ranged from 143 to 199 asexual stages of Plasmodium falciparum parasites per microlitre of blood.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

854 malaria_casesOf 1255 medical visits, 854 resulted in a malaria case diagnosis among people of all ages.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

38 %Three out of eight patients with severe hyperlactatemia died, representing a case fatality rate of 38%.

Côte d'Ivoiresevere hyperlactatemiapublished 2010AIDS research and human retroviruseseurope_pmcdocument of 12 observations

42.4 yearsAt ART initiation, the median age of dually seropositive patients was 42.4 years.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

46.3 %Among HBeAg-positive patients, the cumulative proportion with HBeAg seroclearance was 46.3% (n = 14).

Côte d'Ivoirehépatite Bpublished 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156

8.2 %The prevalence of oral-mucosal lesions among female sex workers in Abidjan, Côte d'Ivoire was 8.2%.

Côte d'Ivoireoral-mucosal lesionsobserved 2013published 2015BMC oral healtheurope_pmcdocument of 7 observations

5.1 %Of the 312 patients initially classified as HIV-2, 16 (5.1%) were reclassified as HIV-1.

Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations

100 %Detectable HCV RNA was identified in 100% of anti-HCV positive HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

92.3 %Among participants who did not sleep under an LLIN the night before the survey, infection prevalence was 92.3%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

12.3 %HIV overall prevalence was 12.3% among the 1,017 cancer cases included.

Côte d'Ivoirecancer (non précisé) · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

0.69 hazard_ratioRisk of all-cause mortality was lower in participants given isoniazid preventive therapy and ART than participants given ART alone (hazard ratio 0.69, 95% CI 0.43–1.10, p=0.12).

Côte d'Ivoiremortalité toutes causespublished 2021The lancet. HIVeurope_pmcdocument of 5 observationsDOI 10.1016/s2352-3018(20)30299-x

8.7 per_100_person_yearsThe incidence of malaria was 8.7 per 100 person-years overall.

Côte d'Ivoirepaludismepublished 2017Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/tmi.12919

10 per_100_person_yearsAfter a median 2.0 year follow-up, the incidence rate of serious HIV-related events was 10.0 per 100 person-years among HIV mono-infected patients.

Côte d'IvoireVIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016

95.9 %HBV genotype E was predominant in 95.9% of 73 HIV-HBV co-infected patients from Côte d'Ivoire.

Côte d'IvoireHBV genotype Epublished 2019Liver international : official journal of the International Association for the Study of teurope_pmcdocument of 4 observationsDOI 10.1111/liv.13975

8.3 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 8.3% for those whose parent/legal guardian was not aware of cervical cancer, 17.4% for those whose parent/legal guardian was aware, and 4.1% for those with non-applicable status in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations

57,833 peopleIn January 2009, a total of 57,833 people living with HIV/AIDS received antiretroviral therapy and follow-up at 274 HIV care centers in Côte d'Ivoire.

Côte d'IvoireVIH/sidaobserved January 2009published 2009Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 5 observations

54.7 %Among febrile participants, 54.7% with bacteraemia had received neither antimalarial nor antibiotic therapy.

Côte d'Ivoirebacteraemiapublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations

30.5 %The main clinical side-effect was peripheral neuropathy (30.5%).

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

8.1 per_100_person-yearsThe incidence of attrition among HIV-infected adults receiving antiretroviral treatment was 8.1 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

13.7 %Cryptococcal meningitis accounted for 13.7% of causes of death.

Côte d'Ivoireméningite cryptococciquepublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations